ID SYI_MYCLE Reviewed; 1059 AA. AC Q9X7E5; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 27-MAR-2024, entry version 133. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=ML1195; GN ORFNames=MLCB458.10; OS Mycobacterium leprae (strain TN). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycobacterium. OX NCBI_TaxID=272631; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=TN; RX PubMed=11234002; DOI=10.1038/35059006; RA Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., RA Wheeler P.R., Honore N., Garnier T., Churcher C.M., Harris D.E., RA Mungall K.L., Basham D., Brown D., Chillingworth T., Connor R., RA Davies R.M., Devlin K., Duthoy S., Feltwell T., Fraser A., Hamlin N., RA Holroyd S., Hornsby T., Jagels K., Lacroix C., Maclean J., Moule S., RA Murphy L.D., Oliver K., Quail M.A., Rajandream M.A., Rutherford K.M., RA Rutter S., Seeger K., Simon S., Simmonds M., Skelton J., Squares R., RA Squares S., Stevens K., Taylor K., Whitehead S., Woodward J.R., RA Barrell B.G.; RT "Massive gene decay in the leprosy bacillus."; RL Nature 409:1007-1011(2001). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL049478; CAB39575.1; -; Genomic_DNA. DR EMBL; AL583921; CAC31576.1; -; Genomic_DNA. DR PIR; E87058; E87058. DR RefSeq; NP_301871.1; NC_002677.1. DR RefSeq; WP_010908192.1; NC_002677.1. DR AlphaFoldDB; Q9X7E5; -. DR SMR; Q9X7E5; -. DR STRING; 272631.gene:17575026; -. DR KEGG; mle:ML1195; -. DR PATRIC; fig|272631.5.peg.2194; -. DR Leproma; ML1195; -. DR eggNOG; COG0060; Bacteria. DR HOGENOM; CLU_001493_1_1_11; -. DR OrthoDB; 9810365at2; -. DR Proteomes; UP000000806; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR CDD; cd00818; IleRS_core; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR Gene3D; 3.90.740.10; Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain; 1. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..1059 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_0000098548" FT MOTIF 59..69 FT /note="'HIGH' region" FT MOTIF 637..641 FT /note="'KMSKS' region" FT BINDING 640 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003" SQ SEQUENCE 1059 AA; 119809 MW; 67FC7659E9399E39 CRC64; MTNSAYPRTD LGADQRGGSP NFPALEAQVL DYWSNDDTFR ASIARCDDAP EYVFYDGPPF ANGLPHYGHL LTGYVKDIVP RYRTMCGYKV ERRFGWDTHG LPAELEVERQ LGITDKSQID AMGIAAFNEA CRKSVLRYTE EWQAYVTRQA RWVDFDNDYK TLDLSYMESV IWAFKQLWDK GLAYESYRVL PYCWRDETPL SNHELRMDDD VYQSRQDPAV TLGFKVLGGD DEDLVGAYLL VWTTTPWTLP SNLAVAVHPD VTYVDVRAGD RRFVLAQARL TAYARELGDE PEVLATYRGA DLLGRHYLPP FQYFYESARN AFQVLPGDFV TTDDGTGIVH IAPAYGEDDM ATADKVGIVP VTPVDSNGCF DATVPDYQGQ HVFEANAQII RDLKNQSGSA AVNGAVLLRH ETYEHPYPHC WRCRNPLIYR AVSSWFVAVT EFRDRMVELN QQITWYPEHV KDGQFGKWLQ GARDWSISRN RYWGTPIPVW KSDDPDYPRI DVYGSLDELE RDFGVRPTNL HRPYIDELTR PNPDDPTGLS TMRRIPDVFD VWFDSGSMPY AQVHYPFEND DWFDGFDSAD SDKQVDAHYP GDFIVEYIGQ ARGWFYTLHV LATALFDRPA FKTCIAHGVV LGSNGQKMSK SLRNYPDVTE IFDRDGSDAM RWFLMASPIL RGGNLIITEP GIREGMRQVL LPLWNAYSFL ALYAPKIGTW HTDVSHVLDR YILAKLAVLR DDLSQAMEVC DISGACEQLR QFTEPLTNWY LRRSRARFWD EDVDAIDTLH TVLEVTARLA APLLPLITEI IWRSVTGGRS VHLTDWPQAN QLPADPDLVA VMDQVRQVCS AASSLRKAKK LRVRLPLPKL VVAVYNSQRL KPYIDLIGDE LNVKQIELTD AIDTYGRFEF TVNARVAGPR LGRDVQAAIK VVKAGEGVAN PDGTLTAGPV VLQPDEYSSR LVAANPEFTA ELPDGSGLVV LDDTVTPELE AEGWAKDRIR ELQELRKLIG LDVSDRIRVL MSVPAERADW ARVHRDFIAR EILATSFEFG EPADSVAIGD GVRVSLLKV //